What the New NHS Landscape Really Means for Pharma
Biologics are no longer just high-cost — they’re a frontline value lever. But are current pathways truly delivering, and what challenges are HCD pharmacists navigating?
Live 1-hour webinar | Hosted by Soar Beyond
Monday April 27th 2026
13:00 - 14:00pm
Zoom
What We'll Cover
-
Why commissioning is changing, and what the policy drivers really mean for pharma
-
What happens when specialised commissioning moves to ICBs and Clusters
-
How ICB clusters shape formularies, pathways and investment decisions
-
The future of IFRs and exceptional access routes in a devolved system
-
How ICBs are redefining value - beyond QALYs to population health and system impact
-
Practical steps pharma can take to engage effectively in the new landscape
Who Should Attend?
*****
Why Soar Beyond?
Soar Beyond works at the intersection of policy, commissioning and frontline delivery, supporting systems to translate strategy into action. In this session, we will share a practical, system-level perspective on how pharma can engage differently and more effectively to support sustainable innovation adoption.